60 Degrees Pharmaceuticals Announces 2024 Annual Results

FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased$443.8 thousand from ($221 thousand) to$222.8 thousand. WASHINGTON, March 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024. Financial Highlights for the Fiscal Year Ended December 31, 2024: ...